Nonalcoholic Steatohepatitis
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
MASH, formerly known as NASH, has been described as the most common disease you’ve never heard of. It stands for metabolic dysfunction-associated steatohepatitis. It’s hard to pronounce, harder to learn you are at risk. MASH is a serious form of 'fatty' liver disease called metabolic dysfunction–associated steatotic liver disease (MASLD, which you have probably never heard of, either). Both conditions develop over time with very few symptoms. Believe it or not, MASLD (formerly called NAFLD) affects two billion people around the world, most of whom are already managing other medical conditions like diabetes, heart disease and/or weight issues. If that sounds like you or a loved one, it’s important to learn more about risk and MASH.
MASLD is a condition in which there is a buildup of fat in a liver. This process happens quietly. Over time, this buildup damages the liver. MASH occurs when ongoing inflammation leads to scarring (“fibrosis”) of the liver. This makes it harder for the liver to function effectively. And MASH that is unmanaged and progresses over time can lead to even more serious disease such as cancer.
Most MASH patients are middle-aged, already receiving care related to diabetes, and likely carrying some extra weight. For a person already living with other medical conditions, adding a new problem to the list – especially if it’s not causing any pain – is a tough sell. But as with so many things, knowledge is power.
Why has my doctor not talked to me about MASH?
There are many possibilities why MASH is not a more routine part of the doctor-patient conversation for at-risk patients. COVID has been very disruptive to primary care and reduced in-office visits for weight checks and physical observation. Additionally, when it comes to MASH and risk, the best defense is a good offense: exercise and weight loss. A doctor that has already counseled a patient to lose weight for other reasons may not be sure what else to do.
So, what else is there?
A PCP deals with a broad range of medical issues and must stay up to date on a broad range of medical updates, trends, and new therapies. A PCP should be willing to write the patient’s playbook. For someone ready to talk about MASH and personal risk or worry, a PCP can help in many ways once the patient has started, or accepted, the dialogue:
Ensuring an appropriate workup. What labs and trends are relevant and at what intervals?
Calling in the experts. Should any specialists be consulted and which ones, where, and in what order? Who would be the best fit for the patient based on their whole-person picture?
Root cause analysis. If a patient has not been successful in losing weight – why? Is there a limitation that physical therapy could help improve with a referral and support?
Staying current on new developments. There is a lot of clinical research happening in MASH and the body of knowledge is growing. It is important for doctors to stay current on relevant advances given the significant portion of a population that MASH is poised to impact.
Published Date June 25, 2024
Latest News
Multiple Myeloma
Life with a rare disease
Experiencing serious health challenges is difficult enough - having a relatively unknown condition adds additional complexity
2024-07-08T22:02:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
2024-06-25T12:15:00Z
Alzheimer's Disease
New Alzheimer’s Disease research breakthroughs
The 2020s have been the most impactful decade so far for the debilitating form of dementia
2024-05-02T18:30:00Z
Breast Cancer
Talking to family about cancer genes
Though this conversation may be difficult, it might be vitally important for your loved ones
2024-02-05T18:30:00Z
Lupus
Lupus (Systemic Lupus Erythematosus) and Diet
Can what you eat make a difference?
2024-04-15T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Learning you need a liver biopsy: staying calm
Approaches to stay in control before, during and after a biopsy
2023-12-27T18:30:00Z
Diabetes
The recent rise of walking as exercise
Grab your sneakers, grab a friend, or grab your dog and get moving!
2023-12-05T18:30:00Z
Renal Cell Carcinoma
Coping with the holidays during cancer treatment
Getting ready to face a new year while facing cancer is no easy task
2023-11-23T18:30:00Z
Multiple Sclerosis (MS)
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
2023-10-25T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2023-09-05T18:30:00Z
Lung Cancer
Talking to loved ones about your clinical trial
How to talk to family and friends when you are thinking of changing cancer treatment plans for a research option
2023-08-14T18:30:00Z
Lung Cancer
Learning you have lung cancer as a non-smoker
Lung cancer can be a shocking diagnosis when you've never smoked - how can it be?
2023-08-15T18:30:00Z
Prostate Cancer
Does a high PSA score always mean cancer?
Learn more about this common test for older men and how it relates to cancer risk
2023-07-10T18:30:00Z
Breast Cancer
Understanding the differences between mastectomy and lumpectomy
Two different surgical options both seeking the same outcome
2023-07-07T18:30:00Z
Lupus
New treatments are on the horizon for lupus patients
From biologics to CAR-T, developments in clinical research for SLE have opened new treatment doors for patients.
2023-05-22T16:15:00Z
Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
2023-04-05T18:30:00Z
Renal Cell Carcinoma
Learning you need a biopsy: staying calm
Approaches to stay in control before, during and after a diagnostic biopsy
2023-03-14T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-03-14T18:30:00Z